NDC 13668-166

OLANZAPINE

Olanzapine

OLANZAPINE is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Torrent Pharmaceuticals Limited. The primary component is Olanzapine.

Product ID13668-166_947b769f-4252-20ba-e053-2995a90a9c93
NDC13668-166
Product TypeHuman Prescription Drug
Proprietary NameOLANZAPINE
Generic NameOlanzapine
Dosage FormTablet
Route of AdministrationORAL
Marketing Start Date2012-04-23
Marketing End Date2021-07-31
Marketing CategoryANDA / ANDA
Application NumberANDA091434
Labeler NameTorrent Pharmaceuticals Limited
Substance NameOLANZAPINE
Active Ingredient Strength3 mg/1
Pharm ClassesAtypical Antipsychotic [EPC]
NDC Exclude FlagN

Packaging

NDC 13668-166-30

30 TABLET in 1 BOTTLE (13668-166-30)
Marketing Start Date2012-04-23
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 13668-166-10 [13668016610]

OLANZAPINE TABLET
Marketing CategoryANDA
Application NumberANDA091434
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2012-04-23
Marketing End Date2017-06-30

NDC 13668-166-60 [13668016660]

OLANZAPINE TABLET
Marketing CategoryANDA
Application NumberANDA091434
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2012-04-23
Marketing End Date2017-06-30

NDC 13668-166-01 [13668016601]

OLANZAPINE TABLET
Marketing CategoryANDA
Application NumberANDA091434
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2012-04-23
Marketing End Date2017-06-30

NDC 13668-166-74 [13668016674]

OLANZAPINE TABLET
Marketing CategoryANDA
Application NumberANDA091434
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2012-04-23
Marketing End Date2017-06-30

NDC 13668-166-43 [13668016643]

OLANZAPINE TABLET
Marketing CategoryANDA
Application NumberANDA091434
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2012-04-23
Marketing End Date2017-06-30

NDC 13668-166-05 [13668016605]

OLANZAPINE TABLET
Marketing CategoryANDA
Application NumberANDA091434
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2012-04-23
Marketing End Date2017-06-30

NDC 13668-166-30 [13668016630]

OLANZAPINE TABLET
Marketing CategoryANDA
Application NumberANDA091434
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2012-04-23
Marketing End Date2017-06-30

Drug Details

Active Ingredients

IngredientStrength
OLANZAPINE2.5 mg/1

OpenFDA Data

SPL SET ID:2cb1bebe-0ced-46d8-bf21-c28a9acc4a15
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 200034
  • 312077
  • 312076
  • 312079
  • 312078
  • 314154
  • 314155
  • 351108
  • 283639
  • 351107

    • Pharmacological Class

    • Atypical Antipsychotic [EPC]

    Medicade Reported Pricing

    13668016630 OLANZAPINE 2.5 MG TABLET

    Pricing Unit: EA | Drug Type:

    NDC Crossover Matching brand name "OLANZAPINE" or generic name "Olanzapine"

    NDCBrand NameGeneric Name
    67877-175OlanzapineOlanzapine
    67877-174OlanzapineOlanzapine
    67877-172OlanzapineOlanzapine
    67877-173OlanzapineOlanzapine
    67877-176OlanzapineOlanzapine
    67877-177OlanzapineOlanzapine
    68084-529OlanzapineOlanzapine
    68084-723OlanzapineOlanzapine
    68084-528OlanzapineOlanzapine
    68084-740OlanzapineOlanzapine
    68084-525OlanzapineOlanzapine
    68258-7095OlanzapineOlanzapine
    68258-7152OlanzapineOlanzapine
    68258-7153OlanzapineOlanzapine
    68258-7154OlanzapineOlanzapine
    68382-365olanzapineolanzapine
    68382-368olanzapineolanzapine
    68258-7096OlanzapineOlanzapine
    68382-367olanzapineolanzapine
    68382-364olanzapineolanzapine
    68382-366olanzapineolanzapine
    68382-369olanzapineolanzapine
    68788-7161OlanzapineOlanzapine
    0517-0955OlanzapineOlanzapine
    69189-5510OlanzapineOlanzapine
    69543-384OlanzapineOlanzapine
    69543-380OlanzapineOlanzapine
    69543-381OlanzapineOlanzapine
    69543-383OlanzapineOlanzapine
    69543-382OlanzapineOlanzapine
    69543-385OlanzapineOlanzapine
    69807-2012OlanzapineOlanzapine
    69807-2011OlanzapineOlanzapine
    69807-2013OlanzapineOlanzapine
    70518-0026OlanzapineOlanzapine
    70518-0148OlanzapineOlanzapine
    70518-0145OlanzapineOlanzapine
    70518-0149OlanzapineOlanzapine
    70518-0314OlanzapineOlanzapine
    70518-0477OlanzapineOlanzapine
    70518-0110OlanzapineOlanzapine
    70518-0616OlanzapineOlanzapine
    70518-0144OlanzapineOlanzapine
    70518-0433OlanzapineOlanzapine
    70518-1206OlanzapineOlanzapine
    70518-0921OlanzapineOlanzapine
    70518-1207OlanzapineOlanzapine
    70518-0615OlanzapineOlanzapine
    70518-1115OlanzapineOlanzapine
    70518-1154OlanzapineOlanzapine
    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.